Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1986 1
1988 1
1989 1
1990 1
1993 1
1995 2
1997 3
1998 1
2000 1
2002 1
2004 2
2007 1
2008 3
2012 1
2013 1
2014 4
2015 3
2016 2
2017 3
2018 1
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
Mortality decrease according to socioeconomic groups - Authors' reply.
Regidor E, Vallejo F, Granados JAT, Viciana-Fernández FJ, de la Fuente L, Barrio G. Regidor E, et al. Among authors: viciana fernandez fj. Lancet. 2017 May 6;389(10081):1795. doi: 10.1016/S0140-6736(17)31158-3. Epub 2017 May 4. Lancet. 2017. PMID: 28495165 No abstract available.
Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.
Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G; SINGLE Investigators. Walmsley SL, et al. N Engl J Med. 2013 Nov 7;369(19):1807-18. doi: 10.1056/NEJMoa1215541. N Engl J Med. 2013. PMID: 24195548 Free article. Clinical Trial.
[Etiopathogenic aspects of Sjögren's syndrome].
Palomino Nicas J, Villar Ortiz J, Viciana Fernández P, Piedra Priego J, Carneado de la Fuente J. Palomino Nicas J, et al. Among authors: viciana fernandez p. Rev Clin Esp. 1984 Jun 15-30;173(5-6):253-8. Rev Clin Esp. 1984. PMID: 6387825 Review. Spanish. No abstract available.
[Candida albicans spondylodiscitis].
de la Torre Lima J, Jiménez-Mejías ME, de Francisco JL, Martín-Sanz V, Viciana Fernández JM, Cañas García-Otero E. de la Torre Lima J, et al. Among authors: viciana fernandez jm. Med Clin (Barc). 1993 Mar 27;100(12):461-3. Med Clin (Barc). 1993. PMID: 7632178 Spanish.
Maraviroc for previously treated patients with R5 HIV-1 infection.
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Gulick RM, et al. N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152. N Engl J Med. 2008. PMID: 18832244 Free PMC article. Clinical Trial.
38 results